Hypertension as a surrogate marker for the activity of anti-VEGF agents

Ann Oncol. 2009 May;20(5):967-70. doi: 10.1093/annonc/mdp206.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Angiogenesis Inhibitors / adverse effects*
  • Blood Pressure / drug effects
  • Humans
  • Hypertension / chemically induced*
  • Hypertension / physiopathology
  • Neoplasms / blood supply
  • Neoplasms / drug therapy*
  • Treatment Outcome
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors*

Substances

  • Angiogenesis Inhibitors
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A